US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 94.215
  • -0.575-0.61%
Trading Mar 28 10:14 ET
5.77BMarket Cap-11256P/E (TTM)

About Blueprint Medicines Company

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolBPMC
Company NameBlueprint Medicines
Listing Date04/30/2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580

Company Executives

  • Name
  • Position
  • Salary
  • Kathryn Haviland
  • Director, President and Chief Executive Officer
  • 6.22M
  • Michael Landsittel
  • Chief Financial Officer
  • 2.36M
  • Tracey L. McCain, Esq.
  • Chief Legal and Compliance Officer
  • 2.34M
  • Dr. Christopher K. Murray, PhD
  • Chief Technical Operations and Quality Officer
  • --
  • Christina Rossi
  • Chief Operating Officer
  • 2.77M
  • Debra Durso-Bumpus
  • Chief People Officer
  • --
  • Dr. Becker Hewes, M.D.
  • Chief Medical Officer
  • --
  • Dr. Philina Lee, PhD
  • Chief Commercial Officer
  • --
  • Dr. Percy H. Carter, M.B.A.,PhD
  • Chief Scientific Officer
  • 4.38M
  • Ariel Hurley
  • Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 1.59M
  • Dr. Fouad Namouni, M.D.
  • President, Research and Development
  • 2.81M
  • Alexis A. Borisy, A.M.
  • Director
  • 323.52K
  • Dr. John Tsai, M.D.
  • Director
  • --
  • Dr. Mark Alan Goldberg, M.D.
  • Independent Director
  • 336.82K
  • Dr. Lynn Seely,M.D.
  • Lead Independent Director
  • 373.59K
  • Daniella Beckman
  • Independent Director
  • 326.51K
  • Lonnel Coats
  • Independent Director
  • 346.39K
  • Dr. Nicholas Lydon, F.R.S.,PhD
  • Independent Director
  • 348.45K
  • Habib J. Dable
  • Independent Director
  • 473.26K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg